## ðŸ§¾ Chronic Kidney Disease (CKD) â€“ Ranges & Interpretation

| **Test / Feature**                  | **Normal Range**                      | **Mild Abnormality**                    | **Moderate Abnormality**                 | **Severe Abnormality**                           | **Critical / End-stage CKD**                                   |
| ----------------------------------- | ------------------------------------- | --------------------------------------- | ---------------------------------------- | ------------------------------------------------ | -------------------------------------------------------------- |
| **Blood Pressure (mmHg)**           | <120/80                               | 121â€“139 / 80â€“89 (pre-HTN)               | 140â€“159 / 90â€“99 (HTN stage 1)            | 160â€“179 / 100â€“109 (HTN stage 2)                  | â‰¥180/110 (hypertensive emergency, CKD risk â†‘â†‘)                 |
| **Specific Gravity (urine)**        | 1.010 â€“ 1.030                         | 1.005 â€“ 1.009 (dilute urine)            | <1.005 (poor concentration)              | Fixed at 1.010 (isosthenuria, renal failure)     | Persistent low SG in CKD                                       |
| **Albumin (urine dipstick)**        | Negative (<30 mg/day)                 | Trace (30â€“300 mg/day, microalbuminuria) | 1+ to 2+ (300 mg â€“ 1 g/day, proteinuria) | 3+ to 4+ (>1 g/day, nephrotic range)             | Persistent heavy proteinuria â†’ progressive CKD                 |
| **Sugar (urine)**                   | Negative                              | Trace (diabetes risk)                   | +1 (poor control DM)                     | +2 to +3 (uncontrolled diabetes)                 | +4 (advanced diabetic nephropathy)                             |
| **Blood Glucose Random**            | 70 â€“ 140 mg/dL                        | 141 â€“ 199 mg/dL (impaired glucose)      | 200 â€“ 300 mg/dL (diabetes, CKD risk â†‘)   | 301 â€“ 400 mg/dL (poor control, nephropathy risk) | >400 mg/dL (emergency, DKA/HHS risk + kidney stress)           |
| **Blood Urea**                      | 7 â€“ 20 mg/dL                          | 21 â€“ 40 mg/dL                           | 41 â€“ 100 mg/dL                           | 101 â€“ 200 mg/dL                                  | >200 mg/dL (severe uremia, end-stage CKD)                      |
| **Serum Creatinine**                | 0.6 â€“ 1.2 mg/dL                       | 1.3 â€“ 2.0 mg/dL                         | 2.1 â€“ 5.0 mg/dL                          | 5.1 â€“ 10 mg/dL                                   | >10 mg/dL (renal failure, dialysis required)                   |
| **Sodium**                          | 135 â€“ 145 mEq/L                       | 130 â€“ 134 or 146 â€“ 150                  | 125 â€“ 129 or 151 â€“ 155                   | 120 â€“ 124 or 156 â€“ 160                           | <120 or >160 (life-threatening, fluid-electrolyte imbalance)   |
| **Potassium**                       | 3.5 â€“ 5.0 mEq/L                       | 5.1 â€“ 5.5 (mild hyperK)                 | 5.6 â€“ 6.5 (moderate hyperK)              | 6.6 â€“ 7.5 (severe hyperK, arrhythmia risk)       | >7.5 (emergency, cardiac arrest risk)                          |
| **Hemoglobin**                      | 13 â€“ 17 g/dL (M) <br>12 â€“ 15 g/dL (F) | 11 â€“ 12 g/dL (mild anemia)              | 8 â€“ 10 g/dL (moderate anemia)            | 6 â€“ 7 g/dL (severe anemia)                       | <6 g/dL (critical, transfusion usually needed)                 |
| **Packed Cell Volume (PCV, %)**     | 40 â€“ 50% (M) <br>36 â€“ 44% (F)         | 30 â€“ 35%                                | 20 â€“ 29%                                 | 15 â€“ 19%                                         | <15% (life-threatening anemia)                                 |
| **White Blood Cell Count (/mmÂ³)**   | 4,000 â€“ 11,000                        | 11,001 â€“ 15,000 (infection risk)        | 15,001 â€“ 25,000                          | 25,001 â€“ 40,000                                  | >40,000 (severe infection, sepsis risk)                        |
| **Red Cell Count (millions/ÂµL)**    | 4.5 â€“ 5.5 (M) <br>4.0 â€“ 5.0 (F)       | 3.5 â€“ 3.9                               | 3.0 â€“ 3.4                                | 2.0 â€“ 2.9                                        | <2.0 (critical anemia)                                         |
| **Red Blood Cell Shape**            | Normal                                | Microcytic / Macrocytic                 | Hypochromic / Target cells               | Dysmorphic RBC (glomerular disease)              | Persistent RBC abnormalities in CKD                            |
| **Platelet Count (/ÂµL)**            | 150k â€“ 400k                           | 100k â€“ 149k (mild â†“)                    | 50k â€“ 99k (moderate â†“)                   | 20k â€“ 49k (severe â†“, bleeding risk)              | <20k (critical, spontaneous bleeding)                          |
| **Prothrombin Complex Concentrate** | INR 0.8 â€“ 1.2                         | INR 1.3 â€“ 1.5                           | INR 1.6 â€“ 2.0                            | INR 2.1 â€“ 3.0                                    | >3.0 (very high bleeding risk in CKD)                          |
| **Basophils (%)**                   | <1%                                   | 1 â€“ 2%                                  | 2 â€“ 3%                                   | 3 â€“ 4%                                           | >4% (advanced allergic/hematologic disorder)                   |
| **Hypertension**                    | No                                    | Yes (controlled)                        | Yes (poorly controlled)                  | Resistant HTN                                    | Malignant HTN (accelerates CKD)                                |
| **Diabetes Mellitus**               | No                                    | Prediabetes                             | Type 2 DM (controlled)                   | Type 2 DM (poor control)                         | Long-standing DM with complications (nephropathy, retinopathy) |
| **Coronary Artery Disease**         | No                                    | Stable angina                           | Prior MI (healed)                        | Unstable angina / multiple vessel disease        | Severe heart failure with CKD                                  |
| **Appetite**                        | Normal                                | Mild loss                               | Moderate loss                            | Severe anorexia                                  | Persistent anorexia (uremia, advanced CKD)                     |
| **Pulmonary Edema**                 | No                                    | Mild (on exertion)                      | Moderate (at rest sometimes)             | Severe (resting, requires O2)                    | Refractory pulmonary edema (dialysis required)                 |
| **Anemia**                          | No                                    | Mild                                    | Moderate                                 | Severe                                           | Life-threatening (requires transfusion/ESKD)                   |
| **Classification (GFR staging)**    | GFR â‰¥90 (Normal)                      | GFR 60â€“89 â†’ Stage 2 CKD                 | GFR 30â€“59 â†’ Stage 3 CKD                  | GFR 15â€“29 â†’ Stage 4 CKD                          | GFR <15 â†’ Stage 5 CKD (End-stage, dialysis/transplant)         |
